This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
Home
>
Industry news
Industry news
Celltrion’s biosimilar trastuzumab approved in Europe
Cancer Research UK to invest £45 million in clinical trials
NICE Final Appraisal Determination recommends use of brodalumab as cost-effective
Hospital Pharmacy Europe issue 88 Winter 2017
CAR T-cell therapy: managing side effects
Marketing authorisation application for apalutamide submitted
Short measures
Optimism for rapid and broad patient access for SMA treatment following NICE update
New updated RPS Hospital Pharmacy Standards published
European real-world audit data provides information on effectiveness of eslicarbazepine acetate
Pharmacy leaders honoured at UKCPA Conference
Continuity of leadership for UKCPA
« Previous
1
2
3
4
5
…
69
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: